4.6 Article

Mutant p53-microRNA-200c-ZEB2-Axis-Induced CPT1C Elevation Contributes to Metabolic Reprogramming and Tumor Progression in Basal-Like Breast Cancers

Related references

Note: Only part of the references are listed.
Article Medicine, Research & Experimental

Oleic acid restores suppressive defects in tissue-resident FOXP3 Tregs from patients with multiple sclerosis

Saige L. Pompura et al.

Summary: Research indicates that oleic acid can enhance the metabolic activity and suppressive function of Tregs, while Tregs from multiple sclerosis patients show a transcriptomic profile more aligned with arachidonic acid. These findings suggest the importance of fatty acids in regulating Treg function within tissues.

JOURNAL OF CLINICAL INVESTIGATION (2021)

Review Oncology

The p53 Pathway and Metabolism: The Tree That Hides the Forest

Airelle Lahalle et al.

Summary: The p53 pathway is a major tumor suppressor pathway that not only prevents abnormal cell propagation by regulating DNA repair and other cellular processes, but also extends to the control of metabolism. Studies suggest that perturbations in p53-associated metabolic activities are linked to cancer development and other pathophysiological conditions.

CANCERS (2021)

Review Cell Biology

Mutant p53 Gain-of-Function: Role in Cancer Development, Progression, and Therapeutic Approaches

Eduardo Alvarado-Ortiz et al.

Summary: Frequent p53 mutations not only abolish tumor suppressor capacities but also confer various gain-of-function activities that impact key pathways in tumor development and progression. The effects of these mutations on proliferation, migration, metabolic reprogramming, and immune evasion constitute major driving forces for human tumors. The interaction of mutp53 with molecules such as AMPK and SREBP1 leads to metabolic reprogramming and favors anabolic pathways in cancer cells.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Review Cell Biology

p53 and Tumor Suppression: It Takes a Network

Anthony M. Boutelle et al.

Summary: TP53 tumor suppressor gene is the most frequently mutated gene in human cancer, playing a crucial role in inhibiting tumorigenesis by transcriptionally regulating target genes. Recent studies have revealed new pathways and transcriptional targets downstream of p53 in regulating genomic integrity, metabolism, redox biology, stemness, and non-cell autonomous signaling in tumor suppression.

TRENDS IN CELL BIOLOGY (2021)

Article Oncology

Mutant p53 Attenuates Oxidative Phosphorylation and Facilitates Cancer Stemness through Downregulating miR-200c-PCK2 Axis in Basal-Like Breast Cancer

Chi-Hong Chao et al.

Summary: miR-200c acts as a tumor suppressor miRNA that regulates epithelial phenotype and cancer stemness. p53 deficiency downregulates miR-200c expression, leading to breast cancer progression. CRISPR-mediated knockout of miR-200c induces metabolic changes similar to those caused by p53 mutations and impairs stemness induced by miR-200c deficiency.

MOLECULAR CANCER RESEARCH (2021)

Review Oncology

Oxidative Stress in Cancer

John D. Hayes et al.

CANCER CELL (2020)

Review Biochemistry & Molecular Biology

NADPH homeostasis in cancer: functions, mechanisms and therapeutic implications

Huai-Qiang Ju et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)

Article Biochemistry & Molecular Biology

Conservation and divergence of the p53 gene regulatory network between mice and humans

Martin Fischer

ONCOGENE (2019)

Article Multidisciplinary Sciences

Metabolic adaptability in metastatic breast cancer by AKR1B10-dependent balancing of glycolysis and fatty acid oxidation

Antoinette van Weverwijk et al.

NATURE COMMUNICATIONS (2019)

Review Nutrition & Dietetics

Glutathione and Nitric Oxide: Key Team Players in Use and Disuse of Skeletal Muscle

Sara Baldelli et al.

NUTRIENTS (2019)

Review Cell Biology

Tumor suppressor p53 and metabolism

Juan Liu et al.

JOURNAL OF MOLECULAR CELL BIOLOGY (2019)

Article Biochemistry & Molecular Biology

Carnitine palmitoyltransferase 1C regulates cancer cell senescence through mitochondria- associated metabolic reprograming

Yongtao Wang et al.

CELL DEATH AND DIFFERENTIATION (2018)

Article Cell Biology

Etomoxir Inhibits Macrophage Polarization by Disrupting CoA Homeostasis

Ajit S. Divakaruni et al.

CELL METABOLISM (2018)

Article Medicine, Research & Experimental

Metabolic shifts in residual breast cancer drive tumor recurrence

Kristina M. Havas et al.

JOURNAL OF CLINICAL INVESTIGATION (2017)

Article Multidisciplinary Sciences

CDCP1 drives triple-negative breast cancer metastasis through reduction of lipid-droplet abundance and stimulation of fatty acid oxidation

Heather J. Wright et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)

Article Genetics & Heredity

InterVar: Clinical Interpretation of Genetic Variants by the 2015 ACMG-AMP Guidelines

Quan Li et al.

AMERICAN JOURNAL OF HUMAN GENETICS (2017)

Review Biochemistry & Molecular Biology

The p53 Pathway: Origins, Inactivation in Cancer, and Emerging Therapeutic Approaches

Andreas C. Joerger et al.

ANNUAL REVIEW OF BIOCHEMISTRY, VOL 85 (2016)

Article Biochemistry & Molecular Biology

Inhibition of fatty acid oxidation as a therapy for MYC-overexpressing triple-negative breast cancer

Roman Camarda et al.

NATURE MEDICINE (2016)

Review Biochemistry & Molecular Biology

p53 as a Regulator of Lipid Metabolism in Cancer

Alejandro Parrales et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)

Review Oncology

Biomarkers in triple negative breast cancer: A review

Budhi S. Yadav et al.

WORLD JOURNAL OF CLINICAL ONCOLOGY (2015)

Review Genetics & Heredity

TP53 Mutations in Human Cancer: Database Reassessment and Prospects for the Next Decade

Bernard Leroy et al.

HUMAN MUTATION (2014)

Review Pharmacology & Pharmacy

Glutathione: new roles in redox signaling for an old antioxidant

Katia Aquilano et al.

FRONTIERS IN PHARMACOLOGY (2014)

Article Biochemistry & Molecular Biology

p53 regulates glucose metabolism by miR-34a

Hwa-Ryeon Kim et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)

Article Biochemistry & Molecular Biology

Depletion of the novel p53-target gene carnitine palmitoyltransferase 1C delays tumor growth in the neurofibromatosis type I tumor model

N. Sanchez-Macedo et al.

CELL DEATH AND DIFFERENTIATION (2013)

Article Multidisciplinary Sciences

Tumour-associated mutant p53 drives the Warburg effect

Cen Zhang et al.

NATURE COMMUNICATIONS (2013)

Article Oncology

Cancer metabolism: fatty acid oxidation in the limelight

Arkaitz Carracedo et al.

NATURE REVIEWS CANCER (2013)

Review Biochemistry & Molecular Biology

Integration of cellular bioenergetics with mitochondrial quality control and autophagy

Bradford G. Hill et al.

BIOLOGICAL CHEMISTRY (2012)

Editorial Material Biochemistry & Molecular Biology

Measuring reactive oxygen and nitrogen species with fluorescent probes: challenges and limitations

Balaraman Kalyanaraman et al.

FREE RADICAL BIOLOGY AND MEDICINE (2012)

Article Medicine, Research & Experimental

A metabolic prosurvival role for PML in breast cancer

Arkaitz Carracedo et al.

JOURNAL OF CLINICAL INVESTIGATION (2012)

Article Multidisciplinary Sciences

Comprehensive molecular portraits of human breast tumours

Daniel C. Koboldt et al.

NATURE (2012)

Article Biochemical Research Methods

RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome

Bo Li et al.

BMC BIOINFORMATICS (2011)

Article Biochemistry & Molecular Biology

Assessing bioenergetic function in response to oxidative stress by metabolic profiling

Brian P. Dranka et al.

FREE RADICAL BIOLOGY AND MEDICINE (2011)

Article Cell Biology

Bioenergetic characterization of mouse podocytes

Yoshifusa Abe et al.

AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2010)

Article Cell Biology

TP53 Mutations in Human Cancers: Origins, Consequences, and Clinical Use

Magali Olivier et al.

COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)

Article Oncology

Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes

Joel S. Parker et al.

JOURNAL OF CLINICAL ONCOLOGY (2009)

Article Multidisciplinary Sciences

Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment

Zachary T. Schafer et al.

NATURE (2009)

Review Oncology

When mutants gain new powers: news from the mutant p53 field

Ran Brosh et al.

NATURE REVIEWS CANCER (2009)

Article Biochemistry & Molecular Biology

CPT1c is localized in endoplasmic reticulum of neurons and has carnitine palmitoyltransferase activity

Adriana Y. Sierra et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2008)

Review Biochemistry & Molecular Biology

Structure-function-rescue: the diverse nature of common p53 cancer mutants

A. C. Joerger et al.

ONCOGENE (2007)

Article Multidisciplinary Sciences

The brain-specific carnitine palmitoyltransferase-1c regulates energy homeostasis

Michael J. Wolfgang et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)

Review Oncology

Rescuing the function of mutant p53

AN Bullock et al.

NATURE REVIEWS CANCER (2001)